<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang L</submitter><funding>Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences</funding><funding>CAMS Endowment Fund</funding><funding>Fundamental Research Funds for Central Universities</funding><funding>National Natural Science Foundation of China</funding><funding>Overseas Expertise Introduction Center for Discipline Innovation ("111Center")</funding><pagination>83</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11744981</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(1)</volume><pubmed_abstract>Influenza-related acute lung injury is a life-threatening condition primarily caused by uncontrolled replication of the influenza virus and intense proinflammatory responses. Cereblon (CRBN) is a protein known for its role in the ubiquitin-proteasome system and as a target of the drug thalidomide. However, the function of CRBN in influenza virus infection remains poorly understood. In this study, we investigated the impact of CRBN on A/Puerto Rico/8/34 (PR8) influenza virus-induced lung injury and its potential as a therapeutic target. Knocking down CRBN in vitro significantly reduces PR8-induced cell death. Using Sftpc-Cre; Crbn&lt;sup>flox/flox&lt;/sup> lung-specific Crbn knockout mice, we demonstrated that Crbn deficiency significantly decreased mortality, weight loss, lung pathology, edema, </pubmed_abstract><journal>BMC infectious diseases</journal><pubmed_title>Lung-specific CRBN knockout attenuates influenza a virus-induced acute lung injury in mice: a potential therapeutic approach.</pubmed_title><pmcid>PMC11744981</pmcid><funding_grant_id>2021-CAMS-JZ001</funding_grant_id><funding_grant_id>BP0820029</funding_grant_id><funding_grant_id>2021-I2M-1-022</funding_grant_id><funding_grant_id>2017PT31017</funding_grant_id><funding_grant_id>81788101</funding_grant_id><funding_grant_id>81570077</funding_grant_id><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Jiang C</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Chang J</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Zhang Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>Lung-specific CRBN knockout attenuates influenza a virus-induced acute lung injury in mice: a potential therapeutic approach.</name><description>Influenza-related acute lung injury is a life-threatening condition primarily caused by uncontrolled replication of the influenza virus and intense proinflammatory responses. Cereblon (CRBN) is a protein known for its role in the ubiquitin-proteasome system and as a target of the drug thalidomide. However, the function of CRBN in influenza virus infection remains poorly understood. In this study, we investigated the impact of CRBN on A/Puerto Rico/8/34 (PR8) influenza virus-induced lung injury and its potential as a therapeutic target. Knocking down CRBN in vitro significantly reduces PR8-induced cell death. Using Sftpc-Cre; Crbn&lt;sup>flox/flox&lt;/sup> lung-specific Crbn knockout mice, we demonstrated that Crbn deficiency significantly decreased mortality, weight loss, lung pathology, edema, </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2025-04-03T23:58:07.634Z</modification><creation>2025-04-03T23:58:07.634Z</creation></dates><accession>S-EPMC11744981</accession><cross_references><pubmed>39833740</pubmed><doi>10.1186/s12879-025-10490-9</doi></cross_references></HashMap>